Back when he was still a Marine Corps. General, James Mattis heard about a great new technology: Blood tests that worked with microscopic samples, the kind of thing that could be useful on the battlefield. As head of Central Command, he told the Army to buy some. But when the Army looked into it, it learned what we’ve since all learned: That maybe Theranos wasn’t being 100% truthful about things.
This did not dissuade Mattis, who wasted no time after retiring from the military in joining Theranos’ board. Nor, now that he’s defense secretary-designate, does he appear particularly eager to follow future Cabinet colleague Steve Mnuchin’s example. And despite purging its board of the likes of former Defense Secretary William Perry and others, Theranos doesn’t seem concerned about retaining the services of a future one, although, in fairness, it does have a lot of other concerns at the moment.
Gen. Mattis joined Theranos’s board in July 2013, a couple of months after his retirement. As of Thursday night, Theranos’s website listed Gen. Mattis as a company director. Theranos referred questions about Gen. Mattis’s directorship to him….
Gen. Mattis also is on the board of directors of General DynamicsCorp., the defense contractor and aerospace firm that builds nuclear-powered submarines, armored vehicles and business jets.
Gen. James Mattis Has Ties to Theranos [WSJ]
Mnuchin, Tapped for Treasury Secretary, Leaves CIT and Sears Boards [WSJ]
Theranos Investor Riley Bechtel Steps Down From Board [WSJ]
Theranos Does Damage Control, Takes Henry Kissinger Off Its Board [Vanity Fair]